Ads
related to: acute myeloid leukemia treatment- Management Considerations
Learn About Disease-Related Factors
Like Molecular Abnormalities.
- Trasfusion Independence
Discover A Potential Treatment
Option For Your Patients.
- Testing For Mutations
Find Mutation Testing Information
For Your Patients With R/R AML.
- Watch A Video On The MOA
Access Physician MOA Video
Materials On HCP Rx Site.
- View Safety Profile
View The Safety Profile For
A R/R AML Treatment Option.
- Physician Rx Resources
Find Clinical Resources, Videos,
And A HCP Testing Brochure.
- Management Considerations
Search results
Recommendations from the AML molecular MRD expert advisory board - Leukemia
Nature· 7 days agoThe standard-of-care treatment for patients with acute myeloid leukemia (AML) is being challenged by new classes of ...
Bob Asmussen | Leukemia survivor Roux doing his part to fight the disease
The News-Gazette, Champaign-Urbana, Ill. via Yahoo News· 1 day agoMay 28—In 2003 at age 9, Champaign's Alex Roux had a bruise on his arm that wouldn't go away. There were no other symptoms. "I wasn't fatigued or tired or anything," Roux said. He was tested ...
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
WROC Rochester· 6 days agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...
PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic...
Nature· 2 days agoSplicing factors are frequently mutated in patients with myelodysplastic syndromes and acute myeloid leukaemia. Recent studies have revealed convergent ...
Texans' John Metchie III wins George Halas award | SportsTalk 790
iHeartRadio· 2 days agoIII was recognized for his perseverance Tuesday as he won the annual George Halas award from the...
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 5 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
NBC 17 Raleigh· 6 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...
The 3 Best Machine Learning Stocks to Quadruple Your Money by 2035
InvestorPlace via Yahoo Finance· 6 days agoOne of the hottest investment trends to jump on at the moment is machine learning stocks to buy....
NCI-MATCH Precision Medicine Clinical Trial
National Cancer Institute· 6 days agoNCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 6 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Ads
related to: acute myeloid leukemia treatment